ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Granules expands APIs

by Jean-François Tremblay
February 27, 2017 | APPEARED IN VOLUME 95, ISSUE 9

Granules, an Indian producer of active pharmaceutical ingredients (APIs), will spend $84 million on an API plant and ancillary facilities, including an R&D unit, in Vishakhapatnam, India. International Finance Corp., a for-profit subsidiary of the World Bank, is enabling the project by buying $48 million in Granules bonds. IFC previously financed various Granules projects, including investment in cleaner production. The new plant will allow Granules to produce higher-end APIs, according to IFC.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment